Clinical Trials Directory

Trials / Unknown

UnknownNCT01373801

Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations

THE EFFICACY AND SAFETY OF HEMCON© BANDAGE FOLLOWING SURGICAL REPAIR IN MANAGEMENT OF POSTPARTUM BLEEDING DUE TO THE MULTIPLE VAGINAL LACERATIONS

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
85 (estimated)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to assess the safety and efficacy of the HemCon GuardaCareXR compared to standard bandaging in subjects with post partum hemorrhage as a result of cervical and vaginal lacerations. The primary endpoint will be a cessation of bleeding at 30 minutes after insertion of the dressing.

Conditions

Interventions

TypeNameDescription
DEVICEThe HemCon GuardaCareThe HemCon GuardaCare (HemCon Medical Technologies Inc., Portland, OR) is a hemostatic dressing made of chitosan, a complex carbohydrate derived from chitin from shellfish and is designed as a hemostatic dressing, and a topical antimicrobial dressing. GuardaCare contains no pro-clotting agents, providing a safe and localized hemostatic solution and is latex free and sterile.
DEVICEControlStandard packing gauze roll bandage.

Timeline

Start date
2011-07-01
Primary completion
2012-07-01
First posted
2011-06-15
Last updated
2011-08-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01373801. Inclusion in this directory is not an endorsement.